(Q48154660)

9 February 2018

title

Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide (English)

1 reference

9 February 2018

author name string

Halliday AJ

1

1 reference

9 February 2018

Bartlett SE

2

1 reference

9 February 2018

Colditz P

3

1 reference

9 February 2018

Smith MT

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

9 February 2018

published in

Life Sciences

1 reference

9 February 2018

volume

65

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

225-236

1 reference

9 February 2018

The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Morphine-3-glucuronide--a potent antagonist of morphine analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Opioids induce convulsions and wet dog shakes in rats: mediation by hippocampal mu, but not delta or kappa opioid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Morphine and enkephalin: analgesic and epileptic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Intrathecal high dose morphine produces hyperalgesia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Epileptiform effects of met-enkephalin, beta-endorphin and morphine: kindling of generalized seizures and potentiation of epileptiform effects by handling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Opioid-induced epileptogenic phenomena: anatomical, behavioral, and electroencephalographic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Effects of naloxone on hippocampal seizure activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Responsiveness of genetically epilepsy-prone rats to intracerebroventricular morphine-induced convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Evidence that physical dependence on morphine is mediated by the ventral midbrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Intrahippocampal injections of a specific mu-receptor ligand PL017 produce generalized convulsions in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Quantitation of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide in Plasma and Cerebrospinal Fluid Using Solid-Phase Extraction and High-Performance Liquid Chromatography with Electrochemical Detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

the apparent affinity of morphine-3-glucuronide at μ1-opioid receptors results from morphine contamination: demonstration using HPLC and radioligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Mu receptor binding of some commonly used opioids and their metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Effects of morphine-3-glucuronide and morphine on the K+-evoked release of [3H]-glutamic acid and [14C]-gamma-aminobutyric acid from rat brain synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Endogenous opiates and nociception: a possible functional role in both pain inhibition and detection as revealed by intrathecal naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900239-8

10.1016/S0024-3205(99)00239-8

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018